Randomised multicenter phase II study of two schedules of docetaxel and gemcitabine or cisplatin/gemcitabine followed by docetaxel as first line treatment for advanced non-small cell lung cancer

Silvia Novello, Alfredo Falcone, Lucio Crinò, Massimo Rinaldi, Mario Nardi, Filippo De Marinis, Maurizio Tonato, Carmelo Tibaldi, Angelo Tinazzi, Francesca Russo, Nicoletta Grassivaro, Giorgio Vittorio Scagliotti

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Randomised multicenter phase II study of two schedules of docetaxel and gemcitabine or cisplatin/gemcitabine followed by docetaxel as first line treatment for advanced non-small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences